Results 141 to 150 of about 156,555 (268)

Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19‐Genotyped Patients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Escitalopram is a frequently prescribed antidepressant drug. CYP2C19 genotype is a major determinant of escitalopram metabolism and treatment outcome. However, real‐life studies show a high degree of genotype–phenotype mismatch in escitalopram metabolism.
Kristine Hole   +3 more
wiley   +1 more source

Hormonal dysregulation in COVID-19: A comparative analysis of cortisol, growth hormone, and IGF-1 levels across different severities of illness. [PDF]

open access: yesCaspian J Intern Med
Hosseinzadeh M   +8 more
europepmc   +1 more source

Socioeconomic Inequities in Eating Disorder‐Related Hospital Utilization Costs in Australia: A Population‐Based Study Using Linked Health Administrative Data

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Aims This research aims to explore the extent of socioeconomic inequities in hospital usage costs for individuals with eating disorders (EDs), analyze its trends, and identify associated factors using Queensland (QLD) administrative health linked data from 2013 to 2019. Methods We have utilized the horizontal inequity (HI) approach to quantify
Moin Ahmed   +11 more
wiley   +1 more source

The Weight of the Number: Perceptions and Practices Surrounding Expected Body Weight Disclosure in Eating Disorder Treatment

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Expected body weight (EBW) determination is common in eating disorder (ED) treatment, yet no evidence‐based guidelines exist for how to discuss EBWs with patients. Clinicians have previously conceptualized these discussions as therapeutic exposures targeting fear of weight gain.
Agatha A. Laboe   +6 more
wiley   +1 more source

Qualitative analysis of staff views on caring for inpatients with delirium and Parkinson's disease: Challenges, tensions and team working. [PDF]

open access: yesJ Parkinsons Dis
Cullinan R   +8 more
europepmc   +1 more source

Motivation to Change, Therapeutic Alliance and Outcome—A Complex Interaction in Patients With Anorexia Nervosa

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective The role of the therapeutic alliance (TA) in treatment outcomes of anorexia nervosa (AN) appears to be less substantial than in other disorders. However, the therapeutic process is a complex trajectory with many variables influencing each other.
Janina Werz   +2 more
wiley   +1 more source

Mechanisms of an Inhibitory Control Training to Reduce Binge Eating—The Randomized Controlled MIND BINGES Trial

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Psychotherapy is the first‐line treatment for eating disorders (EDs), yet only about half of patients benefit long‐term. Bulimia nervosa (BN), Binge‐Eating‐Disorder (BED), and non‐underweight EDs with regular binge eating (> 2 binge‐eating episodes per month within the last 3 months) (OSFED/UFED) form a transdiagnostic group ...
Sebastian M. Max   +7 more
wiley   +1 more source

Empirically Defining “Recurrent” Inappropriate Compensatory Behaviors: Differentiating Binge Eating Disorder From Bulimia Nervosa‐Spectrum Disorders

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective For multiple disorders, DSM‐5‐TR criteria include “recurrent” engagement in behaviors—for example, in the criteria for binge‐eating disorder (BED), “binge eating is not associated with the recurrent use of inappropriate compensatory behavior.”—without operationalizing how frequently a behavior needs to occur to be considered ...
Sophie R. Abber   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy